Holy Basil - Imfinzi (Durvalumab) Interaction
Herbal: Holy Basil
Also Known As: Ocimum tenuiflorum, Ocimum sanctum
Drug: Durvalumab
Brand names:
Imfinzi

Medical Content Editor Dr. Brian Staiger, PharmD
Last updated
Jun 22, 2025
Interaction Details
There were no interactions found between Durvalumab and Holy Basil. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.
Pharmacist Analysis
While holy basil is generally considered a safe supplement with many different medications, and there is no known interaction in this case, it is important to be aware of some of its potential interactions.
Blood Thinning Drugs
- Holy Basil may have mild blood-thinning properties.
- Combining Holy Basil with medications like Warfarin, aspirin, or other anticoagulants/antiplatelet drugs could increase the risk of bleeding.
Blood Pressure Medications
- Holy Basil may have mild hypotensive (blood pressure-lowering) effects.
- Combining Holy Basil with medications used to treat high blood pressure, such as ACE inhibitors or beta-blockers, could potentially enhance the blood pressure-lowering effects.
Diabetes Medications
- Holy Basil may have a hypoglycemic (blood sugar-lowering) effect.
- Combining Holy Basil with diabetes medications like insulin or oral hypoglycemic drugs could potentially enhance the blood sugar-lowering effects.
Sedatives
- Holy Basil has calming properties and may enhance the effects of sedatives or anxiety medications.
- Combining Holy Basil with medications like benzodiazepines or sleep aids could potentially increase drowsiness or sedation.
Always talk to your healthcare provider or pharmacist before starting any new herbal supplement, including Holy Basil. They can provide personalized advice based on your specific medical history, medications, and overall health condition to ensure your safety and well-being.
- Dr. Brian Staiger, PharmDHoly Basil Overview

Durvalumab Overview
-
Durvalumab is used alone to treat non-small cell lung cancer (NSCLC) that spread to nearby tissues and cannot be removed by surgery but has not worsened after being treated with other chemotherapy medications and radiation treatments. It is also used in combination with tremelimumab-actl (Imjudo) and platinum-based chemotherapy to treat a certain type of NSCLC that has spread throughout the lungs and to other parts of the body. Durvalumab injection is also used in combination with chemotherapy agents to treat extensive-stage small cell lung cancer (ES-SCLC) in adults whose cancer has spread throughout the lungs and to other parts of the body. It is also used in combination with chemotherapy agents to treat biliary tract cancer (BTC; cancer in the organs and ducts that make and store bile, the liquid made by the liver) in adults whose cancer has spread to nearby tissues or to other parts of the body. Durvalumab is also used in combination with tremelimumab-actl to treat hepatocellular carcinoma (HCC; a type of liver cancer) that cannot be treated with surgery. Durvalumab injection is in a class of medications called monoclonal antibodies. It works by helping your immune system to slow or stop the growth of cancer cells.
Holy Basil - More Interactions
Holy Basil interacts with 209 drugs
Interaction Rating Key
These severity listings are for informational use only. Never start, stop or otherwise change your therapy before speaking with your provider.
Major | The combined use of these agents is strongly discouraged as serious side effects or other negative outcomes could occur. |
Moderate | Use cautiously under the care of a healthcare professional or avoid this combination. A significant interaction or negative outcome could occur. |
Minor | Be aware that there is a chance of an interaction. Watch for warning signs of a potential interaction. |
Unknown | No interactions have been reported or no interaction data is currently available. |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.